Literature DB >> 23010279

Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis.

Arada Rojana-udomsart1, Chalermchai Mitrpant, Ian James, Campbell Witt, Merrilee Needham, Timothy Day, Lynette Kiers, Alastair Corbett, Patricia Martinez, Steve D Wilton, Frank L Mastaglia.   

Abstract

We compared the carriage frequencies of HLA-DRB3 and its major alleles and of HLA-DRB4 and HLA-DRB5 in an Australian sIBM cohort and a population control group who had previously been genotyped for the HLA-DRB1*03:01 risk allele. There was a strong disease association with the carriage of the DRB3*01:01 allele which was accounted for by its linkage disequilibrium with DRB1*03:01. The carriage of HLA-DRB4 was found to be strongly protective and abrogated the risk effect of HLA-DRB1*03:01. The findings indicate that haplotypic combinations of alleles at the HLA-DRB1 and secondary HLA-DRB loci have important risk modifying effects in sIBM.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010279     DOI: 10.1016/j.jneuroim.2012.09.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.

Authors:  Lisa G Rider; Katalin Dankó; Frederick W Miller
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

Review 2.  Inclusion body myositis - pathomechanism and lessons from genetics.

Authors:  Balázs Murnyák; Levente Bodoki; Melinda Vincze; Zoltán Griger; Tamás Csonka; Rita Szepesi; Andrea Kurucz; Katalin Dankó; Tibor Hortobágyi
Journal:  Open Med (Wars)       Date:  2015-02-26

Review 3.  Genetics in inclusion body myositis.

Authors:  Simon Rothwell; James B Lilleker; Janine A Lamb
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

4.  Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.

Authors:  Simon Rothwell; Robert G Cooper; Ingrid E Lundberg; Peter K Gregersen; Michael G Hanna; Pedro M Machado; Megan K Herbert; Ger J M Pruijn; James B Lilleker; Mark Roberts; John Bowes; Michael F Seldin; Jiri Vencovsky; Katalin Danko; Vidya Limaye; Albert Selva-O'Callaghan; Hazel Platt; Øyvind Molberg; Olivier Benveniste; Timothy R D J Radstake; Andrea Doria; Jan De Bleecker; Boel De Paepe; Christian Gieger; Thomas Meitinger; Juliane Winkelmann; Christopher I Amos; William E Ollier; Leonid Padyukov; Annette T Lee; Janine A Lamb; Hector Chinoy
Journal:  Arthritis Rheumatol       Date:  2017-04-04       Impact factor: 10.995

Review 5.  Inclusion Body Myositis and Neoplasia: A Narrative Review.

Authors:  Laura Damian; Cristian Cezar Login; Carolina Solomon; Cristina Belizna; Svetlana Encica; Laura Urian; Ciprian Jurcut; Bogdan Stancu; Romana Vulturar
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

Review 6.  Emerging therapeutic options for sporadic inclusion body myositis.

Authors:  Lindsay N Alfano; Linda P Lowes
Journal:  Ther Clin Risk Manag       Date:  2015-09-25       Impact factor: 2.423

Review 7.  Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.

Authors:  Qiang Gang; Conceição Bettencourt; Pedro Machado; Michael G Hanna; Henry Houlden
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.